1. Home
  2. CLDX vs CRCT Comparison

CLDX vs CRCT Comparison

Compare CLDX & CRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • CRCT
  • Stock Information
  • Founded
  • CLDX N/A
  • CRCT 1969
  • Country
  • CLDX United States
  • CRCT United States
  • Employees
  • CLDX N/A
  • CRCT N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CRCT Wholesale Distributors
  • Sector
  • CLDX Health Care
  • CRCT Industrials
  • Exchange
  • CLDX Nasdaq
  • CRCT Nasdaq
  • Market Cap
  • CLDX 1.3B
  • CRCT 1.4B
  • IPO Year
  • CLDX 2008
  • CRCT 2021
  • Fundamental
  • Price
  • CLDX $23.36
  • CRCT $5.16
  • Analyst Decision
  • CLDX Buy
  • CRCT Sell
  • Analyst Count
  • CLDX 9
  • CRCT 3
  • Target Price
  • CLDX $50.00
  • CRCT $4.52
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • CRCT 675.1K
  • Earning Date
  • CLDX 08-07-2025
  • CRCT 08-05-2025
  • Dividend Yield
  • CLDX N/A
  • CRCT 18.27%
  • EPS Growth
  • CLDX N/A
  • CRCT 6.92
  • EPS
  • CLDX N/A
  • CRCT 0.31
  • Revenue
  • CLDX $7,559,000.00
  • CRCT $707,780,000.00
  • Revenue This Year
  • CLDX N/A
  • CRCT N/A
  • Revenue Next Year
  • CLDX N/A
  • CRCT $1.18
  • P/E Ratio
  • CLDX N/A
  • CRCT $16.79
  • Revenue Growth
  • CLDX 24.49
  • CRCT N/A
  • 52 Week Low
  • CLDX $14.40
  • CRCT $3.94
  • 52 Week High
  • CLDX $47.00
  • CRCT $7.33
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 64.61
  • CRCT 30.21
  • Support Level
  • CLDX $20.76
  • CRCT $5.80
  • Resistance Level
  • CLDX $23.55
  • CRCT $7.33
  • Average True Range (ATR)
  • CLDX 1.22
  • CRCT 0.25
  • MACD
  • CLDX 0.20
  • CRCT -0.20
  • Stochastic Oscillator
  • CLDX 95.29
  • CRCT 0.00

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

Share on Social Networks: